You are here: Home » Companies » News
Business Standard

USFDA completes inspection of Biocon's Telangana plant, finds no fault

A Form 483, is issued by the USFDA to notify a company's management of any objectionable condition at its manufacturing facility

Press Trust of India  |  New Delhi 

Biocon's facility. Photo: Company's website
A Biocon facility. Photo: Company's website

Monday said the US health regulator has completed the inspection of its without making any observations.

"The Food and Drug Administration (USFDA) conducted a good (GMP) inspection of our (APIs) at from December 12-14, 2018," said in a regulatory filing Monday

The inspection was concluded without any observations and no Form 483 was issued, the company added.

A Form 483, is issued by the USFDA to notify a company's management of any objectionable condition at its The form is issued after completing the inspection.

Shares of were trading 2.07 per cent lower at Rs 633 apiece on the BSE.

First Published: Mon, December 17 2018. 11:35 IST
RECOMMENDED FOR YOU